Table 3 Association of the composite covariate combining WT HLTF and I21R HLTF expression levels (n, %) with patient clinical characteristics
Clinical factor | Categories | n | WT < =20.6 Mut < =2.23 | WT < =20.6 Mut > 2.23 | WT > 20.6 Mut < =2.23 | WT > 20.6 Mut > 2.23 | p-value |
|---|---|---|---|---|---|---|---|
Age | Age < 65 | 57 | 20 (32.8%) | 8 (32%) | 10 (45.5%) | 19 (30.2%) | 0.62 |
Age > =65 | 114 | 41 (67.2%) | 17 (68%) | 12 (54.5%) | 44 (69.8%) | ||
Sex | F | 78 | 26 (42.6%) | 13 (52%) | 11 (50%) | 28 (44.4%) | 0.85 |
M | 93 | 35 (57.4%) | 12 (48%) | 11 (50%) | 35 (55.6%) | ||
Stage | I | 121 | 46 (75.4%) | 17 (68%) | 15 (68.2%) | 43 (68.3%) | 0.81 |
II | 50 | 15 (24.6%) | 8 (32%) | 7 (31.8%) | 20 (31.7%) | ||
Histology | ADC | 122 | 40 (65.6%) | 16 (64%) | 17 (77.3%) | 49 (77.8%) | 0.78 |
OTH | 49 | 21 (34.4%) | 9 (36%) | 5 (22.7%) | 14 (22.2%) | ||
ADC | 122 | 20 (32.8%) | 8 (32%) | 10 (45.5%) | 19 (30.2%) | 0.35 | |
SCC | 42 | 41 (67.2%) | 17 (68%) | 12 (54.5%) | 44 (69.8%) |